SD Biosensor, Inc (KRX:137310)
11,580
-50 (-0.43%)
At close: Jun 5, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Other Products | 273.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Immunochemical Diagnosis | 158.80B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other (Goods, Services, Etc.) | 134.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other (Goods, Services, Etc.) Growth | 1631.53% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Self-monitoring of Blood Sugar Level | 61.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Molecular Diagnostics | 27.80B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Devices Development, Pharmaceutical Development, Raw Material and Compound Manufacturing, and Medical Device Goods | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Service | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
In Vitro Dianostics/Molecular | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
In Vitro Dianostics/Molecular Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Blood Sugar | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Blood Sugar Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Tuberculosis | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cholesterol and Blood Glucose Testing & Monitoring Equipment Goods | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cholesterol and Blood Glucose Testing & Monitoring Equipment Goods Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cholesterol and Blood Glucose Testing & Monitoring Equipment Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Cholesterol and Blood Glucose Testing & Monitoring Equipment Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
America | 252.82B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
America Growth | -34.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 195.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | -88.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | 89.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | -74.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 73.97B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | -82.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India | 31.83B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India Growth | -29.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa | 11.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Africa Growth | -13.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|